Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

June 2022; Volume 42,Issue 6

Reviews

  • Open Access
    Adverse Events in Placebo Arms of Cancer Trials
    JOHANNES E. WOLFF, BIRTE J. WOLFF, MARCEAL M. THIELEN and HOLGER HAUCH
    Anticancer Research June 2022, 42 (6) 2805-2812; DOI: https://doi.org/10.21873/anticanres.15761
  • Open Access
    The Role of Toll-like Receptors in Esophageal Cancer
    SPYRIDON DAVAKIS, ALKISTIS KAPELOUZOU, THEODOROS LIAKAKOS, MARIA MPOURA, DIMITRIOS STERGIOU, STRATIGOULA SAKELLARIOU and ALEXANDROS CHARALABOPOULOS
    Anticancer Research June 2022, 42 (6) 2813-2818; DOI: https://doi.org/10.21873/anticanres.15762

Experimental Studies

  • Open Access
    Cell Dissociation Enzymes Affect Annexin V/Flow-Cytometric Apoptotic Assay Outcomes After miRNA-based Transient Transfection
    CHRISTINA M. GOBIN, JAMES N. MENEFEE, CHAYIL C. LATTIMORE, ANDRIA DOTY and KRISTIANNA M. FREDENBURG
    Anticancer Research June 2022, 42 (6) 2819-2825; DOI: https://doi.org/10.21873/anticanres.15763
  • Open Access
    Altered mRNA Expression Due to Rectal Perforation in a Porcine Model – A Pilot Study
    IOANNIS OIKONOMAKIS, DAVID BRODIN, TAL M. HÖRER, PER SKOOG, JENNY SEILITZ, KRISTOFER F. NILSSON, ADRIAN D. MEEHAN and KJELL JANSSON
    Anticancer Research June 2022, 42 (6) 2827-2833; DOI: https://doi.org/10.21873/anticanres.15764
  • Open Access
    Isoprenylated Coumarin Exhibits Anti-proliferative Effects in Pancreatic Cancer Cells Under Nutrient Starvation by Inhibiting Autophagy
    RONGHAO ZHOU, ERIKA KUSAKA, YIN WANG, JING ZHANG, ANDREW WEBB and DORA CARRICO-MONIZ
    Anticancer Research June 2022, 42 (6) 2835-2845; DOI: https://doi.org/10.21873/anticanres.15765
  • You have access
    Preparation of Micelles Encapsulating Doxorubicin and Their Anticancer Effect in Combination With Tranilast in 3D Spheroids and In Vivo
    TERUKI NII, KANJI YOSHIKAWA, ISSEI TAKEUCHI and KIMIKO MAKINO
    Anticancer Research June 2022, 42 (6) 2847-2857; DOI: https://doi.org/10.21873/anticanres.15766
  • You have access
    Effect of Eribulin on Angiogenesis and the Expression of Endothelial Adhesion Molecules
    ANDREA ABBONA, MATTEO PACCAGNELLA, SIMONETTA ASTIGIANO, STEFANIA MARTINI, NERINA DENARO, FIORELLA RUATTA, OTTAVIA BARBIERI, MARCO MERLANO and ORNELLA GARRONE
    Anticancer Research June 2022, 42 (6) 2859-2867; DOI: https://doi.org/10.21873/anticanres.15767
  • You have access
    PTPN3 Could Βe a Therapeutic Target of Pancreatic Cancer
    HIDEYA ONISHI, NAOYA IWAMOTO, KEITA SAKANASHI, SATOKO KOGA, YASUHIRO OYAMA, KOSUKE YANAI, KATSUYA NAKAMURA, SHUNTARO NAGAI, AKIKO FUJIMURA, KAZUNORI NAKAYAMA, KEIGO OZONO and AKIO YAMASAKI
    Anticancer Research June 2022, 42 (6) 2869-2874; DOI: https://doi.org/10.21873/anticanres.15768
  • You have access
    Murine Double Minute 2 Antagonist Nutlin-3 Enhanced Chemosensitivity in Esophageal Squamous Cell Carcinoma
    KEN ITO, HIROTAKA ISHIDA, FUMIYOSHI FUJISHIMA, YASUHIRO NAKAMURA, TAKURO KONNO, KAZUE ISE, SHUKO HATA, YOHEI OZAWA, YUSUKE TANIYAMA, TAKASHI KAMEI and HIRONOBU SASANO
    Anticancer Research June 2022, 42 (6) 2875-2882; DOI: https://doi.org/10.21873/anticanres.15769
  • You have access
    Feasibility of Gastric Tumor Xenograft (GTX)-derived Cell Lines for Individualized Anti-cancer Drug Screening
    SUNG EUN OH, MI YUN OH, SU MI KIM, SUN YOUNG KIM, JI YEONG AN, JUN HO LEE, TAE SUNG SOHN, JAE MOON BAE and MIN-GEW CHOI
    Anticancer Research June 2022, 42 (6) 2883-2891; DOI: https://doi.org/10.21873/anticanres.15770
  • You have access
    DNMT1 Expression and DNA Methylation in Intraductal Papillary Neoplasms of the Bile Duct
    REIKO DOI, YUKI FUKUMURA, RONG LU, KENICHI HIRABAYASHI, YUKO KINOWAKI, YASUNI NAKANUMA, YOSHIAKIRA KANAI, JUN NAKAHODO, NORIKO SASAHARA, TSUYOSHI SAITO and TAKASHI YAO
    Anticancer Research June 2022, 42 (6) 2893-2902; DOI: https://doi.org/10.21873/anticanres.15771
  • You have access
    Mangosteen Inhibits Growth and Survival of Cervical Cancer Cells
    NATHAN T. GIVENS, LEI ZHAO, ZIWEN ZHU, MARCO LEQUIO, HUAPING XIAO, BRADLEY D. JOHNSON, QIAN BAI, MARK R. WAKEFIELD and YUJIANG FANG
    Anticancer Research June 2022, 42 (6) 2903-2909; DOI: https://doi.org/10.21873/anticanres.15772
  • You have access
    Potent Imidazothiazole-based Inhibitor of BRAF V600E Overcomes Acquired Resistance via Inhibition of RAF Dimerization in PLX4032-resistant Melanoma
    MUNA POUDEL, GARAM KIM, POSHAN YUGAL BHATTARAI, SEUNG SHIN, SEYED-OMAR ZARAEI, CHANG-HYUN OH and HONG SEOK CHOI
    Anticancer Research June 2022, 42 (6) 2911-2921; DOI: https://doi.org/10.21873/anticanres.15773
  • You have access
    LXRβ Activation Inhibits the Proliferation of Small-cell Lung Cancer Cells by Depleting Cellular Cholesterol
    KOREHITO KASHIWAGI, HANAKO SATO-YAZAWA, JUN ISHII, KAKERU KOHNO, ISAAKI TATSUTA, TADASUKE MIYAZAWA, MEGUMI TAKAGI, HIDEKI CHIBA and TAKUYA YAZAWA
    Anticancer Research June 2022, 42 (6) 2923-2930; DOI: https://doi.org/10.21873/anticanres.15774
  • You have access
    Reactivation of p53 by RITA Induces Apoptosis in Human Oral Squamous Cell Carcinoma Cells
    MANABU ENDO, TAKASHI NISHIOKA, KENTO NUMAZAKI, HIROSHI HASEGAWA, TETSU TAKAHASHI, SHUNJI SUGAWARA and HIROYUKI TADA
    Anticancer Research June 2022, 42 (6) 2931-2937; DOI: https://doi.org/10.21873/anticanres.15775

Clinical Studies

  • Open Access
    Cytoreductive Surgery and HIPEC for Malignant Peritoneal Mesothelioma: Outcomes and Survival From an Australian Centre
    RAPHAEL SHAMAVONIAN, ERNEST CHENG, JOSH B. KARPES, SHOMA BARAT, NIMA AHMADI and DAVID L. MORRIS
    Anticancer Research June 2022, 42 (6) 2939-2944; DOI: https://doi.org/10.21873/anticanres.15776
  • Open Access
    Recurrent Mandibular Giant Cell Lesion in Neurofibromatosis Type 1: Second Hit Mutation on the NF1 Gene in the Osseous Lesion
    REINHARD E. FRIEDRICH, ANDREAS M. LUEBKE, ULRICH SCHÜLLER, CHRISTIAN HAGEL, FELIX K. KOHLRUSCH, ILSE WIELAND and MARTIN ZENKER
    Anticancer Research June 2022, 42 (6) 2945-2952; DOI: https://doi.org/10.21873/anticanres.15777
  • Open Access
    Proton Beam Therapy in Elderly Patients With cT1-3N0M0 Non-small Cell Lung Cancer
    MASATOSHI NAKAMURA, HITOSHI ISHIKAWA, KAYOKO OHNISHI, KEIICHIRO BABA, TAKASHI SAITO, TAISUKE SUMIYA, MOTOHIRO MURAKAMI, YUICHI HIROSHIMA, KEI NAKAI, MASASHI MIZUMOTO, TOSHIYUKI OKUMURA and HIDEYUKI SAKURAI
    Anticancer Research June 2022, 42 (6) 2953-2960; DOI: https://doi.org/10.21873/anticanres.15778
  • Open Access
    Does the Use of BioZorb® Result in Smaller Breast Seroma Volume?
    ZEINAB ABOU YEHIA, JENNIFER YOON, MUTLAY SAYAN, SHICHA KUMAR, LARA HATHOUT, MARIA KOWZUN, LINDSAY POTDEVIN, MRIDULA GEORGE, BRUCE G. HAFFTY and NISHA OHRI
    Anticancer Research June 2022, 42 (6) 2961-2965; DOI: https://doi.org/10.21873/anticanres.15779
  • Open Access
    Predictive Performance of Prospectively Applied ISUP and Fuhrman Grade in Nonmetastatic Renal Cell Carcinoma
    KRISTINA FLOR GALTUNG, PETER MÆHRE LAURITZEN, EDUARD BACO, ROLF EIGIL BERG, ANCA MIHAELA NAAS and ERIK RUD
    Anticancer Research June 2022, 42 (6) 2967-2975; DOI: https://doi.org/10.21873/anticanres.15780
  • Open Access
    Neutrophil-to-Lymphocyte Ratio to Predict the Efficacy of Immune Checkpoint Inhibitor in Upper Gastrointestinal Cancer
    EISUKE BOOKA, HIROTOSHI KIKUCHI, RYOMA HANEDA, WATARU SONEDA, SANSHIRO KAWATA, TOMOHIRO MURAKAMI, TOMOHIRO MATSUMOTO, YOSHIHIRO HIRAMATSU and HIROYA TAKEUCHI
    Anticancer Research June 2022, 42 (6) 2977-2987; DOI: https://doi.org/10.21873/anticanres.15781
  • Open Access
    Stereotactic Body Radiotherapy for Stage I Lung Cancer With a New Real-time Tumor Tracking System
    YUICHI HIROSHIMA, YOSHIO TAMAKI, TAKUYA SAWADA, TOSHIKI ISHIDA, KENJI YASUE, KAZUYA SHINODA, TAKASHI SAITO, TAKAYUKI KABURAGI, MORIYUKI KIYOSHIMA, TOSHIYUKI OKUMURA and HIDEYUKI SAKURAI
    Anticancer Research June 2022, 42 (6) 2989-2995; DOI: https://doi.org/10.21873/anticanres.15782
  • You have access
    Early Versus Late Postoperative Radiotherapy in Patients With Prostate Cancer: Results of a Single-centre Retrospective Study
    FRANCESCO PASQUALETTI, ELISA CALISTRI, TAIUSHA FUENTES, ALDO SAINATO, BRUNO MANFREDI, RICCARDO MORGANTI, LUCA GALLI, CHIARA MERCINELLI, ENRICO SAMMARCO, DAVIDE BALDACCINI, GABRIELE CORAGGIO, MARCO PANICHI, PAOLA ANNA ERBA and FABIOLA PAIAR
    Anticancer Research June 2022, 42 (6) 2997-3001; DOI: https://doi.org/10.21873/anticanres.15783
  • You have access
    Hearing Loss After Cisplatin-based Chemoradiotherapy for Locally Advanced Head and Neck Cancer: A Prospective Single-institution Study
    DANIELA MUSIO, MARCO DE VINCENTIIS, PASQUALINA D’URSO, ANGELA MUSACCHIO, VERONICA MAIURI, LUCY ZACCARO, MASSIMO RALLI, CLAUDIA MARCHETTI, ROSARIA TURCHETTA, VINCENZO TOMBOLINI and FRANCESCA DE FELICE
    Anticancer Research June 2022, 42 (6) 3003-3009; DOI: https://doi.org/10.21873/anticanres.15784
  • You have access
    Detection Rate of 68Ga-PSMA PET/CT vs. mpMRI Targeted Biopsy for Clinically Significant Prostate Cancer
    PIETRO PEPE, LUDOVICA PEPE, SEBASTIANO COSENTINO, MASSIMO IPPOLITO, MICHELE PENNISI and FILIPPO FRAGGETTA
    Anticancer Research June 2022, 42 (6) 3011-3015; DOI: https://doi.org/10.21873/anticanres.15785
  • You have access
    Effects of Pegylated Liposomal Doxorubicin and CA125 Level Variability Analysis in Platinum-refractory/resistant Recurrent Ovarian Cancer
    TAKUMA OOYAMA, YUKO SHIMOJI, TADAHARU NAKASONE, YOSHIHISA ARAKAKI, YUSUKE TAIRA, TOMOKO NAKAMOTO, WATARU KUDAKA and YOICHI AOKI
    Anticancer Research June 2022, 42 (6) 3017-3022; DOI: https://doi.org/10.21873/anticanres.15786
  • You have access
    Risk Stratification of Postoperative Pneumonia in Patients Undergoing Subtotal Esophagectomy for Esophageal Cancer
    KEITA TAKAHASHI, KATSUNORI NISHIKAWA, YUICHIRO TANISHIMA, YOSHITAKA ISHIKAWA, TAKANORI KUROGOCHI, MASAMI YUDA, YUJIRO TANAKA, AKIRA MATSUMOTO, FUMIAKI YANO and KEN ETO
    Anticancer Research June 2022, 42 (6) 3023-3028; DOI: https://doi.org/10.21873/anticanres.15787
  • You have access
    Large Tumor Size and High Neutrophil-to-lymphocyte Ratio Predicts Poor Prognosis After Pneumonectomy or Sleeve Lobectomy in Patients With Non-small-cell Lung Cancer
    TAKUMA TSUKIOKA, NOBUHIRO IZUMI, HIROAKI KOMATSU, HIDETOSHI INOUE, RYUICHI ITO, SATOSHI SUZUKI and NORITOSHI NISHIYAMA
    Anticancer Research June 2022, 42 (6) 3029-3034; DOI: https://doi.org/10.21873/anticanres.15788
  • Open Access
    The First Prognostic Tool to Estimate the Risk of Late Grade ≥3 Xerostomia in Patients Irradiated for Head-and-Neck Cancer
    DIRK RADES, BRITTA WARWAS, FLORIAN CREMERS, KARSTEN GERULL, RALPH PRIES, ANKE LEICHTLE, KARL L. BRUCHHAGE, SAMER G. HAKIM and STEVEN E. SCHILD
    Anticancer Research June 2022, 42 (6) 3035-3039; DOI: https://doi.org/10.21873/anticanres.15789
  • Open Access
    Immediate Prostate-specific Antigen Decline After Enzalutamide Following Abiraterone Predicts Survival in Castration-resistant Disease
    NAOHIRO FUJIMOTO, AKINORI MINATO, TSUKASA IGAWA, TASUKU HIROSHIGE, WATARU OBARA, ATSUSHI FUKUDA, YUJIRO NAGATA, YUI MIZUSHIMA, IKKO TOMISAKI and KENICHI HARADA
    Anticancer Research June 2022, 42 (6) 3041-3047; DOI: https://doi.org/10.21873/anticanres.15790
  • Open Access
    The Outcome of Conversion Liver Resection Surgery by Lenvatinib Treatment: A Single Center Experience
    MASAAKI HIDAKA, TAKANOBU HARA, AKIHIKO SOYAMA, RYU SASAKI, HAJIME MATSUSHIMA, TAKAYUKI TANAKA, TAKASHI HAMADA, HAJIME IMAMURA, TOMOHIKO ADACHI, KENGO KANETAKA, HISAMITSU MIYAAKI, SHINJI OKANO and SUSUMU EGUCHI
    Anticancer Research June 2022, 42 (6) 3049-3054; DOI: https://doi.org/10.21873/anticanres.15791
  • You have access
    Preservation of Split Renal Function After Laparoscopic and Robot-assisted Partial Nephrectomy
    KOJIRO OHBA, TOMOHIRO MATSUO, KENSUKE MITSUNARI, YUICHIRO NAKAMURA, HIROMI NAKANISHI, YASUSHI MOCHIZUKI and YASUYOSHI MIYATA
    Anticancer Research June 2022, 42 (6) 3055-3060; DOI: https://doi.org/10.21873/anticanres.15792
  • You have access
    Survival and Early Death Within Three Months from the Start of Immune Checkpoint Inhibitors in Patients With Different Types of Cancer
    CARSTEN NIEDER, SIV GYDA AANES and ELLINOR C. HAUKLAND
    Anticancer Research June 2022, 42 (6) 3061-3066; DOI: https://doi.org/10.21873/anticanres.15793
  • Open Access
    The Effects of Treatment on Peripheral Blood Immune Cell Profile in Pancreatic Ductal Adenocarcinoma (PDAC)
    SKAISTE TULYTE, DAINIUS CHARACIEJUS, REDA MATUZEVICIENE, AUSRA JANIULIONIENE, MANTAS RADZEVICIUS, TADAS ZVIRBLIS and AUDRIUS SILEIKIS
    Anticancer Research June 2022, 42 (6) 3067-3073; DOI: https://doi.org/10.21873/anticanres.15794
  • You have access
    Adverse Cardiovascular Effects of Anti-tumor Therapies in Patients With Breast Cancer: A Single-center Cross-sectional Analysis
    STEPHANIE ROSENKAIMER, TINA SIEBURG, LAURA WINTER, ATHANASIOS MAVRATZAS, WOLF-KARSTEN HOFMANN, RALF-DIETER HOFHEINZ, IBRAHIM AKIN, DANIEL DUERSCHMIED and ANNA HOHNECK
    Anticancer Research June 2022, 42 (6) 3075-3084; DOI: https://doi.org/10.21873/anticanres.15795
  • Open Access
    Improvement of Sleep Disorders During a Course of Radiotherapy for Breast Cancer - Final Results of the Prospective Interventional RADIO-SLEEP Trial
    DIRK RADES, CARLOS A. NARVAEZ, LIESA DZIGGEL, LAURA SPLETTSTÖSSER, STEFAN JANSSEN, DENISE OLBRICH, STEVEN E. SCHILD, SØREN TVILSTED and TROELS W. KJAER
    Anticancer Research June 2022, 42 (6) 3085-3089; DOI: https://doi.org/10.21873/anticanres.15796
  • You have access
    Utility of Drain Fluid Culture and Gram Stain in Early Intervention for Occult Anastomotic Leakage in Colorectal Cancer
    TETSURO TOMINAGA, TAKASHI NONAKA, SHOSABURO OYAMA, YUMA TAKAMURA, SHINTARO HASHIMOTO, TOSHIO SHIRAISHI, TERUMITSU SAWAI and TAKESHI NAGAYASU
    Anticancer Research June 2022, 42 (6) 3091-3098; DOI: https://doi.org/10.21873/anticanres.15797
  • You have access
    Efficacy of Androgen Receptor-targeted Drugs After Prostate Cancer Recurrence With Bone Metastases: PROSTAT-BSI Sub-analysis
    TAIKI KAMIJIMA, HIROSHI YAEGASHI, ATSUSHI MIZOKAMI, KENICHI NAKAJIMA, HIDEYASU MATSUYAMA, TOMOHIKO ICHIKAWA, KOSHIRO NISHIMOTO, SATORU TAKAHASHI, HIROAKI SHIINA, HIROYUKI HORIKOSHI, KATSUYOSHI HASHINE, YUTAKA SUGIYAMA, TAKESHI MIYAO, MANABU KAMIYAMA, KENICHI HARADA, AKITO ITO and HIDEKI ENOKIDA
    Anticancer Research June 2022, 42 (6) 3099-3108; DOI: https://doi.org/10.21873/anticanres.15798
  • You have access
    Evaluation of Lung Toxicity Related to the Treatment With Alectinib Using a Pharmacovigilance Database
    JUNYA SATO, MAYAKO UCHIDA, HARUKA WAKABAYASHI and TADASHI SHIMIZU
    Anticancer Research June 2022, 42 (6) 3109-3116; DOI: https://doi.org/10.21873/anticanres.15799
  • You have access
    Control and Risk Factors of Nausea and Vomiting in Patients With Cervical Cancer Receiving Radiotherapy
    AKANE UNO, SENRI YAMAMOTO, HIROTOSHI IIHARA, HIRONORI FUJII, CHIYOKO MAKITA, YOH HAYASAKI, YUKINO UEDA, MASAYA ITO, MOTOKI TAKENAKA, TOMOYASU KUMANO, MINAKO MORI, MOEKA YASUE, HIROKO KATO-HAYASHI, RYO KOBAYASHI, KEN-ICHIROU MORISHIGE, MASAYUKI MATSUO, HIDEKI HAYASHI and AKIO SUZUKI
    Anticancer Research June 2022, 42 (6) 3117-3123; DOI: https://doi.org/10.21873/anticanres.15800
  • You have access
    Difference in the Overall Survival Between Malignant Central Airway Obstruction Patients Treated by Transbronchial Microwave Ablation and Stent Placement: A Single-institution Retrospective Study
    KOSUKE KASHIWABARA, SHINJI FUJII, SHINSUKE TSUMURA and KAZUHIKO SAKAMOTO
    Anticancer Research June 2022, 42 (6) 3125-3131; DOI: https://doi.org/10.21873/anticanres.15801
  • You have access
    Prognostic Impact of Relative Dose Intensity of Adjuvant Chemotherapy With S-1 on Pancreatic Ductal Adenocarcinoma
    HAJIME MATSUSHIMA, TOMOHIKO ADACHI, MASAAKI HIDAKA, MAMPEI YAMASHITA, TAKASHI HAMADA, SAEKO FUKUI, TAKAYUKI TANAKA, HAJIME IMAMURA, KYOHEI YOSHINO, TOTA KUGIYAMA, AMANE KITASATO, TAKANOBU HARA, AKIHIKO SOYAMA, KAZUMA KOBAYASHI, YORIHISA SUMIDA, TAMOTSU KUROKI and SUSUMU EGUCHI
    Anticancer Research June 2022, 42 (6) 3133-3141; DOI: https://doi.org/10.21873/anticanres.15802
  • You have access
    Compartment-specific Clinical Outcomes in Patients With Soft Tissue Sarcomas of the Thigh
    SEI MORINAGA, AKIHIKO TAKEUCHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, SHINJI MIWA, KENTARO IGARASHI, HIROTAKA YONEZAWA, YOHEI ASANO, SHIRO SAITO, TAKAYUKI NOJIMA and HIROYUKI TSUCHIYA
    Anticancer Research June 2022, 42 (6) 3143-3150; DOI: https://doi.org/10.21873/anticanres.15803
  • You have access
    Efficacy of Cabozantinib for Papillary Compared With Clear-cell Renal Cell Carcinoma Following Immune Checkpoint Inhibitor Treatment
    HIDEKAZU TACHIBANA, TORU INAKAWA, YUKI NEMOTO, HIROKI ISHIHARA, HIRONORI FUKUDA, KAZUHIKO YOSHIDA, JUNPEI IIZUKA, YASUNOBU HASHIMOTO, KAZUNARI TANABE, TSUNENORI KONDO and TOSHIO TAKAGI
    Anticancer Research June 2022, 42 (6) 3151-3158; DOI: https://doi.org/10.21873/anticanres.15804
  • You have access
    Effect of Postoperative Muscle Loss After Resection of Non-small Cell Lung Cancer on Surgical Outcomes
    RYOTA NAKAMURA, SATOSHI YONEYAMA, RIKA TOBITA, SHUSUKE KURIHARA, TAKASHI HATORI, TAKESHI NUMATA, KYOKO OTA, HIDETOSHI YANAI, TAKEO ENDO, YUKINORI INADOME, HIROAKI SATOH and YOSHIHISA INAGE
    Anticancer Research June 2022, 42 (6) 3159-3168; DOI: https://doi.org/10.21873/anticanres.15805
  • You have access
    The Prognostic Relevance of Preoperative CEA and CA19-9 for Ampulla of Vater Carcinoma
    SATOSHI MATSUI, YUSUKE YAMAMOTO, YUKIYASU OKAMURA, TAKAAKI ITO, RYO ASHIDA, KATSUHISA OHGI, MIHOKO YAMADA, SHIMPEI OTSUKA, KATSUHIKO UESAKA and TEIICHI SUGIURA
    Anticancer Research June 2022, 42 (6) 3169-3176; DOI: https://doi.org/10.21873/anticanres.15806
  • You have access
    Preoperative S-1 Therapy for Head and Neck Carcinoma During the Waiting Period Before Surgery
    TAKASHI MATSUKI, CHIHIRO FUSHIMI, SHUNSUKE MIYAMOTO, HIDEAKI TAKAHASHI, TATSUO MASUBUCHI, YUICHIRO TADA, KOUKI MIURA, SHIN-ETSU KAMATA, KOICHI KANO, SHOHEI TSUTSUMI, KAHO MOMIYAMA and TAKU YAMASHITA
    Anticancer Research June 2022, 42 (6) 3177-3183; DOI: https://doi.org/10.21873/anticanres.15807
  • You have access
    Suitability of Oral Rehydration Solution (ORS) for Use in the Cisplatin Short Hydration Method
    YOSHITAKA SAITO, YOH TAKEKUMA, MASAKI KOBAYASHI, NAOFUMI SHINAGAWA, TAKURO NOGUCHI, SATOSHI TAKEUCHI, YASUSHI SHIMIZU, ICHIRO KINOSHITA, HIROTOSHI DOSAKA-AKITA and MITSURU SUGAWARA
    Anticancer Research June 2022, 42 (6) 3185-3193; DOI: https://doi.org/10.21873/anticanres.15808
  • You have access
    Adjuvant Concurrent Chemoradiotherapy Versus Adjuvant Chemotherapy Only in Locally Advanced Non-small-cell Lung Cancer With Involved Microscopic Resection Margin: A Population-based Cohort Study
    CHIH-YEN TU, HUNG-JEN CHEN, TE-CHUN HSIA, HSIN-YUAN FANG, CHIA-CHIN LI and CHUN-RU CHIEN
    Anticancer Research June 2022, 42 (6) 3195-3201; DOI: https://doi.org/10.21873/anticanres.15809
  • You have access
    Contralateral Interhemispheric Transfalcine Approach for Supratentorial Extraventricular Ependymoma Resection
    MATIAS BALDONCINI, GIANLUCA FERINI, GIUSEPPE E. UMANA, BIPIN CHAURASIA, MICKAELA ECHAVARRIA DEMICHELIS, JUAN F. VILLALONGA, PAOLO PALMISCIANO, PAOLO AMICO, SABINO LUZZI, DEREK O. PIPOLO and ALVARO CAMPERO
    Anticancer Research June 2022, 42 (6) 3203-3207; DOI: https://doi.org/10.21873/anticanres.15810
  • You have access
    Successful Treatment of Intrahepatic Cholangiocarcinoma With Liver/Lung Metastasis and Peritoneal Dissemination After Liver Resection
    KAZUKI MATSUMURA, KENSUKE YAMAMURA, ERI ODA, SHINICHI AKAHOSHI, TAKATOSHI ISHIKO, TATSUNORI MIYATA, HIDEAKI MIYAMOTO, TOSHIHIKO MOTOHARA, AKIRA SASAO, YOSHIHIRO KOMOHARA, HIDECHIKA KAWANO and TORU BEPPU
    Anticancer Research June 2022, 42 (6) 3209-3215; DOI: https://doi.org/10.21873/anticanres.15811
  • Open Access
    Republication: Targeting PI3KC2β Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine Tumours
    DANIELLE BOLLER, KATHRIN T. DOEPFNER, ANGELA DE LAURENTIIS, ANA S. GUERREIRO, MARIN MARINOV, TAREK SHALABY, PAUL DEPLEDGE, ANTHONY ROBSON, NAHID SAGHIR, MASAHIKO HAYAKAWA, HIROYUKI KAIZAWA, TOMONOBU KOIZUMI, TAKAHIDE OHISHI, SARAH FATTET, OLIVIER DELATTRE, ANELIA SCHWERI-OLAC, KATRIN HÖLAND, MICHAEL A. GROTZER, KARL FREI, OLIVIER SPERTINI, MICHAEL D. WATERFIELD and ALEXANDRE ARCARO
    Anticancer Research June 2022, 42 (6) 3217-3230; DOI: https://doi.org/10.21873/anticanres.15812

Corrigenda

  • Open Access
    Corrigenda
    Anticancer Research June 2022, 42 (6) 3231-3232;
Back to top
PreviousNext

In this issue

Anticancer Research: 42 (6)
Anticancer Research
Vol. 42, Issue 6
June 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Cytoreductive Surgery and HIPEC for Malignant Peritoneal Mesothelioma: Outcomes and Survival From an Australian Centre
  • Cell Dissociation Enzymes Affect Annexin V/Flow-Cytometric Apoptotic Assay Outcomes After miRNA-based Transient Transfection
  • Altered mRNA Expression Due to Rectal Perforation in a Porcine Model – A Pilot Study
  • Isoprenylated Coumarin Exhibits Anti-proliferative Effects in Pancreatic Cancer Cells Under Nutrient Starvation by Inhibiting Autophagy
  • PTPN3 Could Βe a Therapeutic Target of Pancreatic Cancer
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Corrigenda
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire